Rationing of Treatment for Varicose Veins and Use of New Treatment Methods: A Survey of Practice in the United Kingdom  by Lindsey, B. & Campbell, W.B.
EJVES Extra 12, 19e20 (2006)
doi:10.1016/j.ejvsextra.2006.05.002, available online at http://www.sciencedirect.com onSHORT REPORT
Rationing of Treatment for Varicose Veins and Use of New Treatment
Methods: A Survey of Practice in the United Kingdom
B. Lindsey and W.B. Campbell*
Royal Devon and Exeter Hospital and Peninsula Medical School, Exeter EX2 5DW, UK
Introduction. This study aimed to document the extent of rationing of treatment for varicose veins in the United Kingdom
(UK) national health services and the extent to which new treatments are being used.
Report. Completed questionnaires were received from 75% (307/411) vascular surgeons from all areas of the UK. 46%
restricted access to treatment e 13% in the absence of local referral guidance. 76% would treat patients privately who
did not fulfil their health service criteria. In the health service vs private practice, foam sclerotherapy was used by 28 vs
42; radiofrequency ablation by 8 vs 30; and laser ablation by 16 vs 22.
Discussion. Rationing of health service treatment for varicose veins is common in the UK. More explicit selection criteria
are required for introduction of new treatments and reconfigured services.
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Varicose veins are common and many people want
treatment for a range of symptoms, including discom-
fort and cosmetic embarrassment. When they cause
complications, such as lipodermatosclerosis, ulcers
or bleeding there is a clear medical indication for
advising treatment. However, patients with uncom-
plicated but ‘‘symptomatic’’ varicose veins pose a po-
tentially huge financial burden to health services
throughout Europe. In the United Kingdom they are
widely perceived as deserving low priority despite
national guidance on referrals which advises referral
to a specialist if patients ‘‘have troublesome symp-
toms attributable to their varicose veins, and/or
they or their GP [primary care physician] feel that the
extent, site or size of the varicosities are having a severe
impact on quality of life’’.1 Access to treatment is
‘‘rationed’’ by many hospitals, but the nature and
extent of this rationing is unknown.2
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been the predominant treatment. New methods such
as foam sclerotherapy3 may reduce costs and offer
the possibility of treatment to more patients within
cash limited health services. Their introduction will
require transparent criteria for referral and selection
for treatment. This study aimed to document current
restrictions in varicose vein treatment in the United
Kingdom and also to discover how widely new treat-
ment methods are being used.
Report
Questionnaires were sent to 411 members of the Vas-
cular Society of Great Britain and Ireland during the
latter part of 2005. Responses were received from
307 surgeons (75%) representing all 28 Strategic
Health Authorities in England, and most other areas
throughout the United Kingdom. The Republic of Ire-
land was not included. Among those who responded
to each question, 160 (54%) had local referral guidance
for primary care, and 141 (46%) restricted access to
outpatient consultation e 19 (13%) in the absence of
referral guidance. One hundred and thirty consultants
did not see patients with only cosmetic concerns (129)
20 B. Lindsey and W. B. Campbellor with discomfort/swelling (32). Surgical treatment
was not offered by 120 consultants to all patients
who wanted it; but 76% (143/188) of consultants
said they were prepared to treat patients privately
who did not fulfil their criteria for National Health
Service (NHS) care.
Newer treatments were used (NHS vs private prac-
tice respectively) by the following numbers of consul-
tants: foam sclerotherapy 28 vs 42; radiofrequency
ablation 8 vs 30 and laser ablation 16 vs 22.
Discussion
This study shows that 54% of vascular surgeons
restrict access to outpatient consultation for people
with varicose veins, most as a result of published local
guidance: even for patients attending hospital many
surgeons are not prepared to offer health service treat-
ment to all those who want it. These practices seem
out of tune with recent evidence supporting the clini-
cal and cost effectiveness of varicose vein surgery and
sclerotherapy,4 and also with national guidance which
supports referral as described in the Introduction.1
The high prevalence of varicose veins is a driving
force in rationing of treatment. Other influences are
the beliefs of many clinicians and healthcare pro-
viders that varicose veins are medically unimportant
and that some patients exaggerate symptoms to ob-
tain treatment for cosmetic motives; and scepticism
about the significance of leg symptoms, which are
often not due to concomitant varicose veins.5 A few
people have gross interference with their lives be-
cause of cosmetic concerns, but value judgements
about offering treatment are difficult.
The precise place of new treatments such as foam
sclerotherapy and ablation by laser or radiofrequency
is not yet clear: this survey supports the belief that
their use is more common in private practice than in
the state funded health service. Foam sclerotherapyEJVES Extra Vol 12, August 2006in particular is becoming popular, but its widespread
introduction would require reconfiguration of facili-
ties e transferring from operating theatres, and provi-
sion of ultrasound scanners. These important changes
would be better planned in the context of explicit and
consistent agreements about criteria for treatment of
varicose veins. Data on the services and treatment
methods used for varicose veins in other parts of
Europe would offer interesting comparison.
Acknowledgement
We thank all the surgeons who completed questionnaires for
this study.
Ethics Approval. Approval for this study was sought and
granted through the Research Governance processes of the
Royal Devon and Exeter Healthcare Trust (study number
509110: reference number 2004/12/146).
Funding. None.
Contributions of authors. Bruce Campbell conceived and
supervised the study and was principal author. Ben Lindsey
assisted in design of the study, conducted the survey and
collated the figures.
References
1 National Institute for Clinical Excellence NICE 2001/043. Referral
advice. Issued: 20 December 2001.
2 HARRIS MRE, DAVIES RJ, BROWN S, JONES SM, EYRES PS, CHESTER JF.
Surgical treatment of varicose veins: the effect of rationing.
Ann R Coll Surg Engl 2006;88:37e39.
3 CAMPBELL B. New treatments for varicose veins. BMJ 2002;324:
689e690.
4 RATCLIFFE J, BRAZIER JE, CAMPBELL WB, PALFREYMAN S, MACINTYRE JB,
MICHAELS JA. Cost effectiveness analysis of surgery versus conser-
vative treatment for uncomplicated varicose veins in a random-
ized clinical trial. Br J Surg 2006;93:182e186.
5 BRADBURY A, EVANS C, ALLAN P, LEE A, RUCKLEY CV, FOWKES FG.
What are the symptoms of varicose veins? Edinburgh vein study
cross sectional population survey. BMJ 1999;318:353e356.
Accepted 9 May 2006
